InvestorsHub Logo

scottsmith

06/25/17 5:22 PM

#187340 RE: petemantx #187338

You ask a lot of great questions!

JTORENCE

06/25/17 7:41 PM

#187344 RE: petemantx #187338

petemantx I believe that there would have to be to be a large marketing effort by a BP for them to even consider changing from Otezla or whatever other current drug they prescribe. BP has the structure, bucks and hundreds of sales reps to see doctors and promo the drug. Word of mouth ain't gonna cut it. Just take a look at the dozens of TV advertisements that are aired daily promoting BP's drugs and IPIX has no one on staff that has the credentials to market their drugs. Another reason why Leo is gonna partner up or sell out right to BP. IMO . Have a good evening.

someconcerns

06/25/17 9:02 PM

#187354 RE: petemantx #187338

Prurisol, if approved and if it has a superior safety and efficacy profile to the drugs presently on the market would quickly begin to be prescribed by all dermatologists who keep up with developments in the field. Nonetheless, a BP would also begin marketing it to try to capture market share as rapidly as possible.